Sruthi Kalavagunta
Papers
1
Total Citations
2
H-Index
1
About
Dr. Sruthi Kalavagunta is a pioneering oncologist whose research focuses on the intersection of advanced radiation oncology and hepatocellular carcinoma (HCC), particularly in cases complicated by vascular invasion. Her most cited work, "Co-relation of Portal Vein Tumour Thrombus Response With Survival Function Following Robotic Radiosurgery in Vascular Invasive Hepatocellular Carcinoma" (2024), represents a significant contribution to the treatment of one of the most challenging presentations of liver cancer. In this study, she systematically demonstrates that robotic radiosurgery can achieve meaningful tumor thrombus response, directly correlating with improved survival outcomes—a finding that challenges the historically poor prognosis for patients with portal vein tumor thrombus. While her citation count is currently modest at 2, the clinical relevance of her work is substantial, offering a targeted, non-invasive alternative for a patient population with limited therapeutic options. Dr. Kalavagunta’s research bridges the gap between cutting-edge radiation technology and practical hepatobiliary oncology, providing a framework for integrating stereotactic body radiotherapy into multidisciplinary management. Her work is particularly valuable for clinicians and researchers seeking to optimize survival in vascular invasive HCC, marking her as an emerging voice in the field of radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1